SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-008488
Filing Date
2023-03-22
Accepted
2023-03-22 09:00:10
Documents
12
Period of Report
2023-03-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40219
  Complete submission text file 0001493152-23-008488.txt   216034

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vynt-20230320.xsd EX-101.SCH 3227
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vynt-20230320_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vynt-20230320_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3701
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 23751565
SIC: 8071 Services-Medical Laboratories